These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8618620)

  • 21. Pertussis: persistent pathogen, imperfect vaccines.
    Yeh SH
    Expert Rev Vaccines; 2003 Feb; 2(1):113-27. PubMed ID: 12901603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of injection site on reactogenicity and immunogenicity of acellular and whole-cell pertussis component diphtheria-tetanus-pertussis vaccines in infants.
    Tapiainen T; Cherry JD; Heininger U
    Vaccine; 2005 Oct; 23(43):5106-12. PubMed ID: 16023771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and serological reactions after immunization of children in Ghana, West Africa, with the Japanese acellular pertussis vaccine.
    Biritwum RB; Isomura S; Ofosu-Amaah S; Sato Y
    Dev Biol Stand; 1985; 61():539-43. PubMed ID: 2872130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucosal immunisation of murine neonates using whole cell and acellular Pertussis vaccines.
    Hale C; Humphreys IR; Hussell T; Bowe F; Clare S; Pickard D; Preston A; Del Giudice G; Dougan G
    Vaccine; 2004 Sep; 22(27-28):3595-602. PubMed ID: 15315838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acellular pertussis vaccines pertinent issues.
    Mathew JL
    Indian Pediatr; 2008 Sep; 45(9):727-9. PubMed ID: 18820375
    [No Abstract]   [Full Text] [Related]  

  • 26. Safety and effectiveness of an acellular pertussis vaccine in subjects with Down's syndrome.
    Li Volti S; Mattina T; Mauro L; Bianca S; Anfuso S; Ursino A; Mollica F
    Childs Nerv Syst; 1996 Feb; 12(2):100-2. PubMed ID: 8674075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New whooping cough vaccine for adolescents and adults.
    FDA Consum; 2005; 39(5):6. PubMed ID: 16421987
    [No Abstract]   [Full Text] [Related]  

  • 28. Rapid and accurate typing of Bordetella pertussis targeting genes encoding acellular vaccine antigens using real time PCR and High Resolution Melt analysis.
    Chan WF; Maharjan RP; Reeves PR; Sintchenko V; Gilbert GL; Lan R
    J Microbiol Methods; 2009 Jun; 77(3):326-9. PubMed ID: 19341769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prophylaxis of pertussis: development and use of acellular pertussis vaccine].
    Chuprinina RP; Alekseeva IA; Ozeretskovskiĭ NA
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (1):99-105. PubMed ID: 16532655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [General immunogenesis after oral uptake of killed Pertussis bacteria].
    Hof H; Finger H
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):282-8. PubMed ID: 4154597
    [No Abstract]   [Full Text] [Related]  

  • 31. The persistence of pertussis and developments in vaccination strategies.
    Heininger U
    Lancet Respir Med; 2015 Sep; 3(9):668-670. PubMed ID: 26380881
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy of an acellular pertussis vaccine among adolescents and adults.
    Ward JI; Cherry JD; Chang SJ; Partridge S; Lee H; Treanor J; Greenberg DP; Keitel W; Barenkamp S; Bernstein DI; Edelman R; Edwards K;
    N Engl J Med; 2005 Oct; 353(15):1555-63. PubMed ID: 16221778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new vaccine for whooping cough?
    Cottingham K
    J Proteome Res; 2007 Jul; 6(7):2409. PubMed ID: 17650534
    [No Abstract]   [Full Text] [Related]  

  • 34. The control of pertussis--2007 and beyond.
    Halperin SA
    N Engl J Med; 2007 Jan; 356(2):110-3. PubMed ID: 17215528
    [No Abstract]   [Full Text] [Related]  

  • 35. A new era of research into Bordetella pertussis pathogenesis.
    Preston A; Maskell DJ
    J Infect; 2002 Jan; 44(1):13-6. PubMed ID: 11972412
    [No Abstract]   [Full Text] [Related]  

  • 36. Characterization and clinical study on the acellular pertussis vaccine produced by a combination of column purified pertussis toxin and filamentous hemagglutinin.
    Ginnaga A; Morokuma K; Aihara K; Sakou M; Imaizumi A; Suzuki Y; Sato H; Sato Y; Ueda K; Kuno-Sakai H
    Tokai J Exp Clin Med; 1988; 13 Suppl():59-69. PubMed ID: 2908528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laboratory investigation of immune responses to acellular pertussis vaccines when used for boosting adolescents after primary immunisation with whole cell pertussis vaccines: a comparison with data from clinical study.
    Reynolds E; Walker B; Xing D; Southern J; Asokanathan C; Dagg B; Corbel M; Miller E
    Vaccine; 2006 Apr; 24(16):3248-57. PubMed ID: 16480794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acellular vaccines for preventing pertussis in children.
    Bailey J
    Am Fam Physician; 2011 Sep; 84(5):504. PubMed ID: 21888301
    [No Abstract]   [Full Text] [Related]  

  • 39. Effectiveness of two pertussis vaccines in preterm Danish children.
    Hviid A
    Vaccine; 2009 May; 27(23):3035-8. PubMed ID: 19428916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Consensus on the immunological defence of pertussis].
    Diao LD; Xu AQ;
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Jun; 32(6):550-3. PubMed ID: 21781469
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.